SGRY logo

Surgery Partners (SGRY) EBITDA

Annual EBITDA

$501.40 M
+$55.30 M+12.40%

December 31, 2024

Summary

Performance

1-Year Change

+12.4%

3-Year Change

+25.04%

5-Year Change

+61.74%

15-Year Change

-

SGRY EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

92.38%
SGRY annual EBITDA is higher than 92.38% of companies in Healthcare sector

High & Low

All-time High

$501.40 M
SGRY annual EBITDA is currently at an all-time high

3-Year Low

$401.00 M
SGRY annual EBITDA is currently +25.04% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
SGRY previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
SGRY next annual earnings announcement has not yet been scheduled

OtherSGRYprofitabilitymetrics:

Annual Revenue

$3.11 B
SGRY annual revenue is $3.11 billion

Annual Net Income

-$168.10 M
SGRY annual net profit is -$168.10 million

Annual EBIT

$348.80 M
SGRY annual earnings before interest & taxes is $348.80 million

Annual EPS

-$1.33
SGRY annual earnings per share is -$1.33

Quarterly EBITDA

$161.00 M
+$49.90 M+44.91%

December 31, 2024

Summary

Performance

3-Month Change

+44.91%

1-Year Change

+44.91%

3-Year Change

+17.09%

5-Year Change

+17.09%

SGRY Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

92.06%
SGRY quarterly EBITDA is higher than 92.06% of companies in Healthcare sector

High & Low

All-time High

$161.00 M
SGRY quarterly EBITDA is currently at an all-time high

3-Year Low

$80.10 M
SGRY quarterly EBITDA is currently +101.00% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
SGRY previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 7, 2025
SGRY next earnings announcement is scheduled for May 7, 2025

OtherSGRYprofitabilitymetrics:

Quarterly Revenue

$864.40 M
SGRY quarterly revenue is $864.40 million

Quarterly Net Income

-$108.50 M
SGRY quarterly net profit is -$108.50 million

Quarterly EBIT

$127.10 M
SGRY quarterly earnings before interest & taxes is $127.10 million

Quarterly EPS

-$0.86
SGRY quarterly earnings per share is -$0.86

TTM EBITDA

$501.40 M
+$28.50 M+6.03%

December 31, 2024

Summary

Performance

3-Month Change

+6.03%

1-Year Change

+6.03%

3-Year Change

+25.04%

5-Year Change

+25.04%

SGRY TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

91.89%
SGRY TTM EBITDA is higher than 91.89% of companies in Healthcare sector

High & Low

All-time High

$501.40 M
SGRY TTM EBITDA is currently at an all-time high

3-Year Low

$401.00 M
SGRY TTM EBITDA is currently +25.04% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
SGRY previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 7, 2025
SGRY next earnings announcement is scheduled for May 7, 2025

OtherSGRYprofitabilitymetrics:

TTM Revenue

$3.11 B
SGRY TTM revenue is $3.11 billion

TTM Net Income

-$168.10 M
SGRY TTM net profit is -$168.10 million

TTM EBIT

$348.80 M
SGRY TTM earnings before interest & taxes is $348.80 million

TTM EPS

-$1.33
SGRY TTM earnings per share is -$1.33

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

$501.40 M
SGRY annual EBITDA is $501.40 million

Annual Net Income

-$168.10 M
SGRY annual net profit is -$168.10 million

Annual Interest Expense

$201.70 M
SGRY annual interest expense is $201.70 million

Annual Income Tax

$134.60 M
SGRY annual income tax is $134.60 million

Annual D&A

$152.60 M
SGRY annual depreciation & amortization is $152.60 million

SGRY EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+12.4%+44.9%+6.0%
3 y3 years+25.0%+17.1%+25.0%
5 y5 years+61.7%+17.1%+25.0%

SGRY EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+25.0%at high+101.0%at high+25.0%
5 y5-yearat high+80.5%at high+277.9%at high+102.2%
alltimeall timeat high+744.3%at high+279.3%at high+2129.5%

Surgery Partners EBITDA History

DateAnnualQuarterlyTTM
Dec 2024
$501.40 M(+12.4%)
$161.00 M(+44.9%)
$501.40 M(+6.0%)
Sep 2024
-
$111.10 M(-7.1%)
$472.90 M(-0.1%)
Jun 2024
-
$119.60 M(+9.0%)
$473.30 M(-0.5%)
Mar 2024
-
$109.70 M(-17.2%)
$475.70 M(+6.6%)
Dec 2023
$446.10 M(-3.0%)
$132.50 M(+18.8%)
$446.10 M(+2.0%)
Sep 2023
-
$111.50 M(-8.6%)
$437.40 M(+1.8%)
Jun 2023
-
$122.00 M(+52.3%)
$429.80 M(+4.2%)
Mar 2023
-
$80.10 M(-35.3%)
$412.30 M(-10.4%)
Dec 2022
$460.00 M(+14.7%)
$123.80 M(+19.2%)
$460.00 M(-2.9%)
Sep 2022
-
$103.90 M(-0.6%)
$473.70 M(+3.3%)
Jun 2022
-
$104.50 M(-18.2%)
$458.60 M(+4.5%)
Mar 2022
-
$127.80 M(-7.1%)
$438.80 M(+9.4%)
Dec 2021
$401.00 M(+44.3%)
$137.50 M(+54.8%)
$401.00 M(+4.1%)
Sep 2021
-
$88.80 M(+4.8%)
$385.30 M(+13.6%)
Jun 2021
-
$84.70 M(-5.9%)
$339.10 M(+5.1%)
Mar 2021
-
$90.00 M(-26.1%)
$322.50 M(+16.1%)
Dec 2020
$277.80 M(-10.4%)
$121.80 M(+185.9%)
$277.80 M(+12.0%)
Sep 2020
-
$42.60 M(-37.4%)
$248.00 M(-12.3%)
Jun 2020
-
$68.10 M(+50.3%)
$282.80 M(-2.2%)
Mar 2020
-
$45.30 M(-50.8%)
$289.30 M(-6.7%)
Dec 2019
$310.00 M
$92.00 M(+18.9%)
$310.00 M(+68.4%)
DateAnnualQuarterlyTTM
Sep 2019
-
$77.40 M(+3.8%)
$184.10 M(+9.1%)
Jun 2019
-
$74.60 M(+13.0%)
$168.70 M(+9.3%)
Mar 2019
-
$66.00 M(-294.7%)
$154.30 M(+6.3%)
Dec 2018
$145.20 M(-37.5%)
-$33.90 M(-154.7%)
$145.20 M(-18.9%)
Sep 2018
-
$62.00 M(+3.0%)
$179.10 M(+52.9%)
Jun 2018
-
$60.20 M(+5.8%)
$117.10 M(+10.4%)
Mar 2018
-
$56.90 M(+15.8%)
$106.06 M(-54.2%)
Jun 2017
-
$49.16 M(-10.0%)
$231.55 M(-4.7%)
Mar 2017
-
$54.59 M(-30.9%)
$243.05 M(+4.6%)
Dec 2016
$232.30 M(+291.2%)
$78.97 M(+61.7%)
$232.30 M(+265.5%)
Sep 2016
-
$48.83 M(-19.5%)
$63.55 M(-6.0%)
Jun 2016
-
$60.65 M(+38.3%)
$67.61 M(+19.8%)
Mar 2016
-
$43.85 M(-148.8%)
$56.42 M(-5.0%)
Dec 2015
$59.39 M(-9.8%)
-$89.78 M(-269.8%)
$59.39 M(-60.9%)
Sep 2015
-
$52.88 M(+6.9%)
$152.00 M(+25.0%)
Jun 2015
-
$49.47 M(+5.7%)
$121.61 M(+68.6%)
Mar 2015
-
$46.81 M(+1550.1%)
$72.14 M(+184.8%)
Dec 2014
$65.87 M(-5.8%)
$2.84 M(-87.4%)
$25.33 M(+12.6%)
Sep 2014
-
$22.49 M
$22.49 M
Dec 2013
$69.89 M(-2.5%)
-
-
Dec 2012
$71.66 M
-
-

FAQ

  • What is Surgery Partners annual EBITDA?
  • What is the all time high annual EBITDA for Surgery Partners?
  • What is Surgery Partners annual EBITDA year-on-year change?
  • What is Surgery Partners quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Surgery Partners?
  • What is Surgery Partners quarterly EBITDA year-on-year change?
  • What is Surgery Partners TTM EBITDA?
  • What is the all time high TTM EBITDA for Surgery Partners?
  • What is Surgery Partners TTM EBITDA year-on-year change?

What is Surgery Partners annual EBITDA?

The current annual EBITDA of SGRY is $501.40 M

What is the all time high annual EBITDA for Surgery Partners?

Surgery Partners all-time high annual EBITDA is $501.40 M

What is Surgery Partners annual EBITDA year-on-year change?

Over the past year, SGRY annual EBITDA has changed by +$55.30 M (+12.40%)

What is Surgery Partners quarterly EBITDA?

The current quarterly EBITDA of SGRY is $161.00 M

What is the all time high quarterly EBITDA for Surgery Partners?

Surgery Partners all-time high quarterly EBITDA is $161.00 M

What is Surgery Partners quarterly EBITDA year-on-year change?

Over the past year, SGRY quarterly EBITDA has changed by +$49.90 M (+44.91%)

What is Surgery Partners TTM EBITDA?

The current TTM EBITDA of SGRY is $501.40 M

What is the all time high TTM EBITDA for Surgery Partners?

Surgery Partners all-time high TTM EBITDA is $501.40 M

What is Surgery Partners TTM EBITDA year-on-year change?

Over the past year, SGRY TTM EBITDA has changed by +$28.50 M (+6.03%)